- Home
- GDHG vs SNGX Comparison
GDHG vs SNGX Comparison
Compare GDHG & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDHG
- SNGX
- Stock Information
- Founded
- GDHG 2008
- SNGX 1987
- Country
- GDHG China
- SNGX United States
- Employees
- GDHG N/A
- SNGX N/A
- Industry
- GDHG Services-Misc. Amusement & Recreation
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- GDHG Consumer Discretionary
- SNGX Health Care
- Exchange
- GDHG Nasdaq
- SNGX Nasdaq
- Market Cap
- GDHG 9.0M
- SNGX 7.4M
- IPO Year
- GDHG 2023
- SNGX 1987
- Fundamental
- Price
- GDHG $2.41
- SNGX $2.46
- Analyst Decision
- GDHG
- SNGX
- Analyst Count
- GDHG 0
- SNGX 0
- Target Price
- GDHG N/A
- SNGX N/A
- AVG Volume (30 Days)
- GDHG 444.2K
- SNGX 621.9K
- Earning Date
- GDHG 02-13-2025
- SNGX 03-14-2025
- Dividend Yield
- GDHG N/A
- SNGX N/A
- EPS Growth
- GDHG N/A
- SNGX N/A
- EPS
- GDHG 1.62
- SNGX N/A
- Revenue
- GDHG $25,549,903.00
- SNGX $364,183.00
- Revenue This Year
- GDHG N/A
- SNGX N/A
- Revenue Next Year
- GDHG N/A
- SNGX $76.64
- P/E Ratio
- GDHG $1.47
- SNGX N/A
- Revenue Growth
- GDHG N/A
- SNGX N/A
- 52 Week Low
- GDHG $1.14
- SNGX $1.83
- 52 Week High
- GDHG $42.35
- SNGX $14.88
- Technical
- Relative Strength Index (RSI)
- GDHG 56.46
- SNGX 37.72
- Support Level
- GDHG $1.98
- SNGX $2.03
- Resistance Level
- GDHG $2.84
- SNGX $3.44
- Average True Range (ATR)
- GDHG 0.34
- SNGX 0.34
- MACD
- GDHG -0.03
- SNGX -0.06
- Stochastic Oscillator
- GDHG 70.95
- SNGX 26.06
About GDHG Golden Heaven Group Holdings Ltd.
Golden Heaven Group Holdings Ltd is an offshore holding company. Through the operating entities in China, It manages and operates six properties consisting of amusement parks, water parks, and complementary recreational facilities. The parks offer a broad selection of exhilarating and recreational experiences, including both thrilling and family-friendly rides, water attractions, gourmet festivals, circus performances, and high-tech facilities. The parks collectively contain nearly 159 rides and attractions. The firm's revenue is generated from selling access to rides and attractions, charging fees for special event rentals, and collecting regular rental payments from commercial tenants.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).